Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells.

Benjamin, Daniel I

Diacylglycerol Metabolism and Signaling Is a Driving Force Underlying FASN Inhibitor Sensitivity in Cancer Cells. [electronic resource] - ACS chemical biology Jul 2015 - 1616-23 p. digital

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't

1554-8937

10.1021/acschembio.5b00240 doi


Antineoplastic Agents--pharmacology
Cell Line, Tumor
Cell Survival--drug effects
Diglycerides--metabolism
Drug Resistance, Neoplasm
Enzyme Inhibitors--pharmacology
Fatty Acid Synthases--antagonists & inhibitors
Glucose--metabolism
Humans
Neoplasms--drug therapy
Protein Kinase C--metabolism
Signal Transduction--drug effects